Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HE44
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 155 | 157 | PF00675 | 0.405 |
CLV_NRD_NRD_1 | 300 | 302 | PF00675 | 0.669 |
CLV_NRD_NRD_1 | 357 | 359 | PF00675 | 0.526 |
CLV_NRD_NRD_1 | 439 | 441 | PF00675 | 0.680 |
CLV_PCSK_FUR_1 | 153 | 157 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 155 | 157 | PF00082 | 0.464 |
CLV_PCSK_KEX2_1 | 300 | 302 | PF00082 | 0.669 |
CLV_PCSK_KEX2_1 | 357 | 359 | PF00082 | 0.665 |
CLV_PCSK_KEX2_1 | 439 | 441 | PF00082 | 0.634 |
CLV_PCSK_KEX2_1 | 80 | 82 | PF00082 | 0.624 |
CLV_PCSK_PC1ET2_1 | 357 | 359 | PF00082 | 0.665 |
CLV_PCSK_PC1ET2_1 | 80 | 82 | PF00082 | 0.532 |
CLV_PCSK_SKI1_1 | 201 | 205 | PF00082 | 0.552 |
CLV_PCSK_SKI1_1 | 238 | 242 | PF00082 | 0.684 |
CLV_PCSK_SKI1_1 | 81 | 85 | PF00082 | 0.617 |
DEG_APCC_DBOX_1 | 226 | 234 | PF00400 | 0.535 |
DOC_CYCLIN_yCln2_LP_2 | 88 | 94 | PF00134 | 0.427 |
DOC_MAPK_gen_1 | 153 | 161 | PF00069 | 0.397 |
DOC_MAPK_gen_1 | 6 | 15 | PF00069 | 0.523 |
DOC_MAPK_MEF2A_6 | 153 | 161 | PF00069 | 0.464 |
DOC_PP2B_LxvP_1 | 88 | 91 | PF13499 | 0.467 |
DOC_USP7_MATH_1 | 179 | 183 | PF00917 | 0.658 |
DOC_USP7_MATH_1 | 255 | 259 | PF00917 | 0.728 |
DOC_USP7_MATH_1 | 368 | 372 | PF00917 | 0.741 |
DOC_USP7_MATH_1 | 394 | 398 | PF00917 | 0.584 |
DOC_USP7_MATH_1 | 74 | 78 | PF00917 | 0.642 |
DOC_USP7_UBL2_3 | 45 | 49 | PF12436 | 0.618 |
DOC_USP7_UBL2_3 | 7 | 11 | PF12436 | 0.615 |
DOC_WW_Pin1_4 | 246 | 251 | PF00397 | 0.628 |
DOC_WW_Pin1_4 | 258 | 263 | PF00397 | 0.559 |
DOC_WW_Pin1_4 | 269 | 274 | PF00397 | 0.655 |
DOC_WW_Pin1_4 | 304 | 309 | PF00397 | 0.652 |
LIG_14-3-3_CanoR_1 | 100 | 109 | PF00244 | 0.439 |
LIG_14-3-3_CanoR_1 | 300 | 308 | PF00244 | 0.677 |
LIG_14-3-3_CanoR_1 | 9 | 14 | PF00244 | 0.592 |
LIG_14-3-3_CterR_2 | 439 | 441 | PF00244 | 0.634 |
LIG_BIR_III_4 | 184 | 188 | PF00653 | 0.563 |
LIG_BRCT_BRCA1_1 | 128 | 132 | PF00533 | 0.374 |
LIG_BRCT_BRCA1_1 | 46 | 50 | PF00533 | 0.391 |
LIG_deltaCOP1_diTrp_1 | 29 | 35 | PF00928 | 0.658 |
LIG_EH_1 | 319 | 323 | PF12763 | 0.655 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.524 |
LIG_FHA_1 | 117 | 123 | PF00498 | 0.427 |
LIG_FHA_1 | 140 | 146 | PF00498 | 0.439 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.681 |
LIG_FHA_2 | 101 | 107 | PF00498 | 0.291 |
LIG_FHA_2 | 82 | 88 | PF00498 | 0.592 |
LIG_Integrin_isoDGR_2 | 285 | 287 | PF01839 | 0.515 |
LIG_Integrin_isoDGR_2 | 380 | 382 | PF01839 | 0.735 |
LIG_LIR_Gen_1 | 105 | 116 | PF02991 | 0.539 |
LIG_LIR_Gen_1 | 129 | 140 | PF02991 | 0.353 |
LIG_LIR_Gen_1 | 278 | 284 | PF02991 | 0.528 |
LIG_LIR_Gen_1 | 56 | 65 | PF02991 | 0.590 |
LIG_LIR_Nem_3 | 105 | 111 | PF02991 | 0.536 |
LIG_LIR_Nem_3 | 129 | 135 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 278 | 282 | PF02991 | 0.625 |
LIG_LIR_Nem_3 | 433 | 438 | PF02991 | 0.647 |
LIG_PCNA_yPIPBox_3 | 164 | 178 | PF02747 | 0.558 |
LIG_Pex14_2 | 108 | 112 | PF04695 | 0.329 |
LIG_Pex14_2 | 92 | 96 | PF04695 | 0.431 |
LIG_PTB_Apo_2 | 415 | 422 | PF02174 | 0.516 |
LIG_PTB_Phospho_1 | 415 | 421 | PF10480 | 0.518 |
LIG_SH2_PTP2 | 158 | 161 | PF00017 | 0.412 |
LIG_SH2_SRC | 421 | 424 | PF00017 | 0.499 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.412 |
LIG_SH2_STAT5 | 22 | 25 | PF00017 | 0.519 |
LIG_SH2_STAT5 | 401 | 404 | PF00017 | 0.519 |
LIG_SH3_1 | 420 | 426 | PF00018 | 0.655 |
LIG_SH3_3 | 210 | 216 | PF00018 | 0.664 |
LIG_SH3_3 | 302 | 308 | PF00018 | 0.675 |
LIG_SH3_3 | 420 | 426 | PF00018 | 0.673 |
LIG_SUMO_SIM_par_1 | 141 | 146 | PF11976 | 0.564 |
LIG_TRAF2_1 | 103 | 106 | PF00917 | 0.443 |
MOD_CK1_1 | 234 | 240 | PF00069 | 0.473 |
MOD_CK1_1 | 249 | 255 | PF00069 | 0.678 |
MOD_CK1_1 | 258 | 264 | PF00069 | 0.601 |
MOD_CK1_1 | 397 | 403 | PF00069 | 0.551 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.686 |
MOD_CK1_1 | 70 | 76 | PF00069 | 0.592 |
MOD_CK2_1 | 100 | 106 | PF00069 | 0.427 |
MOD_Cter_Amidation | 153 | 156 | PF01082 | 0.433 |
MOD_GlcNHglycan | 136 | 139 | PF01048 | 0.449 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.747 |
MOD_GlcNHglycan | 251 | 254 | PF01048 | 0.741 |
MOD_GlcNHglycan | 257 | 260 | PF01048 | 0.725 |
MOD_GlcNHglycan | 302 | 305 | PF01048 | 0.789 |
MOD_GlcNHglycan | 370 | 373 | PF01048 | 0.745 |
MOD_GlcNHglycan | 374 | 377 | PF01048 | 0.743 |
MOD_GlcNHglycan | 405 | 409 | PF01048 | 0.549 |
MOD_GlcNHglycan | 412 | 416 | PF01048 | 0.738 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.464 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.604 |
MOD_GSK3_1 | 251 | 258 | PF00069 | 0.600 |
MOD_GSK3_1 | 300 | 307 | PF00069 | 0.705 |
MOD_GSK3_1 | 353 | 360 | PF00069 | 0.714 |
MOD_GSK3_1 | 368 | 375 | PF00069 | 0.765 |
MOD_GSK3_1 | 70 | 77 | PF00069 | 0.578 |
MOD_N-GLC_1 | 100 | 105 | PF02516 | 0.421 |
MOD_N-GLC_1 | 269 | 274 | PF02516 | 0.500 |
MOD_N-GLC_1 | 368 | 373 | PF02516 | 0.824 |
MOD_N-GLC_1 | 61 | 66 | PF02516 | 0.663 |
MOD_NEK2_1 | 147 | 152 | PF00069 | 0.402 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.725 |
MOD_NEK2_1 | 299 | 304 | PF00069 | 0.809 |
MOD_PIKK_1 | 160 | 166 | PF00454 | 0.547 |
MOD_PKA_1 | 300 | 306 | PF00069 | 0.743 |
MOD_PKA_1 | 357 | 363 | PF00069 | 0.626 |
MOD_PKA_2 | 172 | 178 | PF00069 | 0.627 |
MOD_PKA_2 | 299 | 305 | PF00069 | 0.728 |
MOD_PKA_2 | 357 | 363 | PF00069 | 0.654 |
MOD_PKA_2 | 58 | 64 | PF00069 | 0.436 |
MOD_Plk_1 | 147 | 153 | PF00069 | 0.407 |
MOD_Plk_1 | 277 | 283 | PF00069 | 0.713 |
MOD_Plk_1 | 350 | 356 | PF00069 | 0.650 |
MOD_Plk_1 | 397 | 403 | PF00069 | 0.612 |
MOD_Plk_1 | 55 | 61 | PF00069 | 0.588 |
MOD_Plk_2-3 | 229 | 235 | PF00069 | 0.432 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.554 |
MOD_ProDKin_1 | 246 | 252 | PF00069 | 0.627 |
MOD_ProDKin_1 | 258 | 264 | PF00069 | 0.559 |
MOD_ProDKin_1 | 269 | 275 | PF00069 | 0.657 |
MOD_ProDKin_1 | 304 | 310 | PF00069 | 0.648 |
MOD_SUMO_for_1 | 338 | 341 | PF00179 | 0.675 |
MOD_SUMO_rev_2 | 39 | 47 | PF00179 | 0.424 |
MOD_SUMO_rev_2 | 77 | 82 | PF00179 | 0.431 |
TRG_DiLeu_BaLyEn_6 | 118 | 123 | PF01217 | 0.395 |
TRG_DiLeu_BaLyEn_6 | 166 | 171 | PF01217 | 0.560 |
TRG_ENDOCYTIC_2 | 158 | 161 | PF00928 | 0.412 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.586 |
TRG_ER_diArg_1 | 153 | 156 | PF00400 | 0.546 |
TRG_ER_diArg_1 | 299 | 301 | PF00400 | 0.677 |
TRG_ER_diArg_1 | 438 | 440 | PF00400 | 0.570 |
TRG_NLS_MonoExtN_4 | 4 | 10 | PF00514 | 0.563 |
TRG_Pf-PMV_PEXEL_1 | 121 | 125 | PF00026 | 0.402 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3F7 | Leptomonas seymouri | 65% | 100% |
A0A0S4IKR5 | Bodo saltans | 34% | 100% |
A0A1X0NLV4 | Trypanosomatidae | 44% | 100% |
A0A3S7WZ21 | Leishmania donovani | 84% | 98% |
A4I1F0 | Leishmania infantum | 84% | 98% |
C9ZJX0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
E9AXI7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
Q4Q9Y5 | Leishmania major | 81% | 100% |
V5BKV0 | Trypanosoma cruzi | 49% | 100% |